Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
IsraelRecruitingPHASE1
Conditions
Systemic Sclerosis (SSc) · Idiopathic Inflammatory Myopathy (IIM) · Rheumatoid Arthritis (RA) · Systemic Lupus Erythematosus (SLE) · Multiple Sclerosis (MS) Primary Progressive · Multiple Sclerosis (MS) Secondary Progressive · Neuromyelitis Optica Spectrum Disorder (NMOSD) · Myasthenia Gravis (MG) · Antiphospholipid Antibody Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hadassah MO, Jerusalem, Israel
Contact: Study coordinator (Polina Stepensky, MD, Professor) · Fainak@haddasah.org.il · +97226776679Contact: Principal Investigator (Polina Stepensky, MD, Professor)Chamutal Gur, MD, Professor (Sub-investigator)